Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $4.08M | $174M | $249M | $310M | $400M |
| Revenue growth | — | 4175.6% | 43.1% | 24.4% | 29.0% |
| Operating income | -$175M | -$51.7M | -$59.6M | -$70.5M | -$45.4M |
| Operating margin | -4281.2% | -29.7% | -23.9% | -22.7% | -11.3% |
| Net income | -$180M | -$52.5M | -$55.3M | -$51.1M | -$35.5M |
| Net margin | -4414.6% | -30.1% | -22.2% | -16.5% | -8.9% |
| EPS (diluted) | -$4.24 | -$1.15 | -$1.13 | -$1.02 | -$0.71 |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$143M | -$49.2M | $2.94M | $26.1M | -$10.7M |
| Capital expenditures | $1.39M | $2.20M | $5.42M | $5.17M | $4.34M |
| Free cash flow | -$144M | -$51.4M | -$2.48M | $20.9M | -$15.1M |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $321M | $402M | $443M | $456M | $468M |
| Total assets | — | $527M | $597M | $1.01B | $1.07B |
| Total liabilities | — | $188M | $228M | $649M | $686M |
| Shareholders' equity | $234M | $339M | $369M | $361M | $381M |
| Retained earnings | — | -$689M | -$745M | -$796M | -$831M |
| Shares (wtd avg diluted) | 42.5M | 45.7M | 48.9M | 50.0M | 50.3M |
Every figure is extracted from Immunocore Holdings plc’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.